x

Syros Pharmaceuticals, Inc. (Nasdaq:SYRS)

Health Care/Life Sciences • Biotechnology
CIK 1556263
Company

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Address
35 CambridgePark Drive
4th floor
Cambridge, Massachusetts 02140-2325
Employees
117
Stock Info
Close
$7.15
Day Range
7.04 - 7.60
52 Week Range
2.09 - 8.17
Average volume
316.78K
Short Interest
1.02M (02/15/24)
% of Float Shorted
5.63%
Market Cap
$197.65M
Revenue
$14.88M
Net Income
-$94.65M
2020 Sales Growth
N/A
Rev. per Employee
$75.17K
P/E Ratio
N/A
EPS
-$3.76
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Peter Karl Wirth
Independent Director
Marsha H Fanucci MBA
Independent Director
Srinivas Akkaraju MD, PhD
Independent Director
Timothy C Tyson MBA
Independent Director
Andrew M Oh MBA
Independent Director
S Gail Eckhardt MD
Independent Director
Richard A Young PhD
Independent Director
Deborah L Dunsire MD
SEC filings
DateFormEvent
2 Oct, 2024 4
18 Sep, 2024 4
18 Sep, 2024 4
12 Sep, 2024 4
12 Sep, 2024 4
5 Sep, 2024 8-K
12 Aug, 2024 8-K
2 Aug, 2024 SC 13G/A
31 Jul, 2024 S-8
31 Jul, 2024 10-Q
2 Jul, 2024 4
28 Jun, 2024 144
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
7 Jun, 2024 4
6 Jun, 2024 8-K
4 Jun, 2024 4
4 Jun, 2024 4
14 May, 2024 10-Q
23 Apr, 2024 DEFA14A
23 Apr, 2024 ARS
23 Apr, 2024 DEF 14A
12 Apr, 2024 PRE 14A
5 Apr, 2024 4
3 Apr, 2024 144
2 Apr, 2024 4
2 Apr, 2024 4
2 Apr, 2024 4
2 Apr, 2024 4
2 Apr, 2024 4
2 Apr, 2024 4
2 Apr, 2024 144
27 Mar, 2024 S-8
27 Mar, 2024 10-K
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
7 Feb, 2024 SC 13G/A
8 Jan, 2024 8-K
2 Jan, 2024 SC 13G
26 Dec, 2023 4
26 Dec, 2023 SC 13D/A
19 Dec, 2023 8-K
19 Dec, 2023 424B5
14 Dec, 2023 4
12 Dec, 2023 144
8 Dec, 2023 4
6 Dec, 2023 8-K
6 Dec, 2023 144
5 Dec, 2023 4
5 Dec, 2023 4
14 Nov, 2023 10-Q
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
20 Oct, 2023 4
20 Oct, 2023 SC 13D
2 Oct, 2023 8-K CEO Change
19 Sep, 2023 4
19 Sep, 2023 4
19 Sep, 2023 4
14 Sep, 2023 4
11 Aug, 2023 8-K
8 Aug, 2023 10-Q
2 Aug, 2023 4
31 Jul, 2023 144
21 Jul, 2023 8-K
18 Jul, 2023 4
17 Jul, 2023 144
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 8-K
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 4
25 May, 2023 8-K
10 May, 2023 10-Q
1 May, 2023 424B5
28 Apr, 2023 EFFECT
26 Apr, 2023 CORRESP
21 Apr, 2023 DEFA14A
21 Apr, 2023 DEF 14A
21 Apr, 2023 ARS
20 Apr, 2023 4/A
20 Apr, 2023 4/A
7 Apr, 2023 UPLOAD
6 Apr, 2023 S-3
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
10 Mar, 2023 8-K
2 Mar, 2023 S-8
2 Mar, 2023 10-K
21 Feb, 2023 4
21 Feb, 2023 4
21 Feb, 2023 4
21 Feb, 2023 4
21 Feb, 2023 4
21 Feb, 2023 4
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
13 Feb, 2023 SC 13G/A
30 Jan, 2023 SC 13G/A
25 Jan, 2023 SC 13G
9 Jan, 2023 8-K
22 Dec, 2022 EFFECT
20 Dec, 2022 CORRESP
16 Dec, 2022 8-K/A
12 Dec, 2022 8-K
1 Dec, 2022 S-3/A
1 Dec, 2022 8-K/A
30 Nov, 2022 CORRESP
14 Nov, 2022 10-Q
10 Nov, 2022 SC 13G/A
28 Oct, 2022 UPLOAD
14 Oct, 2022 S-3
13 Oct, 2022 3
13 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4
11 Oct, 2022 4/A
6 Oct, 2022 8-K
3 Oct, 2022 4
21 Sep, 2022 D
20 Sep, 2022 SC 13G
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 S-4MEF
19 Sep, 2022 SC 13G
19 Sep, 2022 3
19 Sep, 2022 3
19 Sep, 2022 4
19 Sep, 2022 4
19 Sep, 2022 4
16 Sep, 2022 8-K
16 Sep, 2022 SC 13D/A
16 Sep, 2022 S-8
15 Sep, 2022 8-K
15 Sep, 2022 425
2 Sep, 2022 8-K
2 Sep, 2022 425
9 Aug, 2022 10-Q
9 Aug, 2022 424B3
8 Aug, 2022 EFFECT
4 Aug, 2022 CORRESP
1 Aug, 2022 S-4/A
20 Jul, 2022 UPLOAD
18 Jul, 2022 S-4
18 Jul, 2022 DEL AM
13 Jul, 2022 SC 13D
13 Jul, 2022 SC 13D
8 Jul, 2022 SC 13G
6 Jul, 2022 425
6 Jul, 2022 8-K
5 Jul, 2022 8-K
5 Jul, 2022 425
7 Jun, 2022 8-K
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
2 Jun, 2022 4
16 May, 2022 10-Q
21 Apr, 2022 DEFA14A
21 Apr, 2022 DEF 14A
11 Apr, 2022 SC 13G/A
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 4
15 Mar, 2022 10-K
15 Mar, 2022 S-8
8 Mar, 2022 8-K
17 Feb, 2022 4
17 Feb, 2022 4
17 Feb, 2022 4
17 Feb, 2022 4
17 Feb, 2022 4
17 Feb, 2022 4
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G
11 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G/A
3 Feb, 2022 SC 13G/A
10 Jan, 2022 8-K
6 Jan, 2022 4
5 Nov, 2021 10-Q
13 Oct, 2021 3
13 Oct, 2021 4
13 Oct, 2021 8-K
28 Sep, 2021 4
28 Sep, 2021 3
20 Sep, 2021 8-K
10 Sep, 2021 3
10 Sep, 2021 8-K
10 Sep, 2021 4
5 Aug, 2021 10-Q
1 Jul, 2021 4
10 Jun, 2021 4
10 Jun, 2021 8-K CEO Change
10 Jun, 2021 4
10 Jun, 2021 4
10 Jun, 2021 4
10 Jun, 2021 4
10 Jun, 2021 4
10 Jun, 2021 4
10 Jun, 2021 3
10 Jun, 2021 4
26 May, 2021 8-K
6 May, 2021 10-Q
29 Apr, 2021 DEFA14A
29 Apr, 2021 DEF 14A
17 Mar, 2021 4
10 Mar, 2021 SC 13G/A
4 Mar, 2021 S-8
4 Mar, 2021 10-K
25 Feb, 2021 8-K
19 Feb, 2021 4
19 Feb, 2021 4
19 Feb, 2021 4
19 Feb, 2021 4
19 Feb, 2021 4
19 Feb, 2021 4
18 Feb, 2021 4
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G/A
10 Feb, 2021 4/A
10 Feb, 2021 4
8 Feb, 2021 SC 13G/A
5 Feb, 2021 SC 13G/A
3 Feb, 2021 CT ORDER
2 Feb, 2021 SC 13G/A
1 Feb, 2021 SC 13G/A
27 Jan, 2021 424B3
20 Jan, 2021 8-K
20 Jan, 2021 424B5
19 Jan, 2021 424B5
19 Jan, 2021 8-K
19 Jan, 2021 EFFECT
14 Jan, 2021 CORRESP
13 Jan, 2021 UPLOAD
11 Jan, 2021 8-K
7 Jan, 2021 S-3
Last update:2024-03-06 13:30:05.325801
Syros Pharmaceuticals, Inc. by TradingView

Sign Up to Subscribe